Background. No satisfactory treatment exists for chronic rejection (CR) after lung transplantation (LT).
Our objective was to assess whether ozone (O 3 ) treatment could ameliorate CR.
Methods. Male Sprague-Dawley inbred rats (n [ 36) were randomly assigned into four groups: (1) control (n [ 6), (2) sham (n [ 6), (3) LT (n [ 12) , and (4) O 3 -LT (n [ 12). Animals underwent left LT. O 3 was rectally administered daily for 2 weeks before LT (from 20 to 50 mg) and 3 times/wk (50 mg/dose) up to 3 months. CR; acute rejection; and Hspb27, Prdx, Epas1, Gpx3, Vegfa, Sftpa1, Sftpb, Plvap, Klf2, Cldn5, Thbd, Dsip, Fmo2, and Sepp1 mRNA gene expression were determined.
Results. Severe CR was observed in all animals of LT group, but none of the O 3 -LT animals showed signs of CR, just a mild acute rejection was observed in 1 animal. A significant decrease of Hspb27, Prdx, Epas1, Gpx3, Vegfa, Sftpa1, Sftpb, Plvap, Klf2, Cldn5, Thbd, Dsip, and Fmo2 gene expression in the O 3 -LT group was observed Conclusions. O 3 therapy significantly delayed the onset of CR regulating the expression of genes involved in its pathogenesis. No known immunosuppressive therapy has been capable of achieving similar results. From a translational point of view, O 3 therapy could become a new adjuvant treatment for CR in patients undergoing LT.
(Ann Thorac Surg 2017;104:458-64) Ó 2017 by The Society of Thoracic Surgeons L ung transplantation (LT) is an effective and applicable treatment in the final stage of non-malignant lung disease. The procedure has developed rapidly since its inception in the 1980s, and clinical outcomes are continually improving. However, long-term outcomes are compromised by chronic rejection (CR) and immunosuppression [1, 2] . Even though more than 47,000 LTs have been performed worldwide, the 5-year survival rate has remained stagnant at approximately 50% since the 1990s [1, 3] . CR is a fibroproliferative process resulting in progressive and irreversible airflow obstruction that is responsible for low long-term survival and is the leading cause of death. The incidence of CR is usually high in the first 2 years after LT, and nearly 50% of the recipients will experience CR by 5 years after LT, with a median survival of 3 years. Even after that, patients remain at undefined cumulative risk between 5 and 10 years after LT. Currently, CR is difficult to detect in the preclinical stage, and few satisfactory treatments exist [4, 5] .
Oxidative stress (OS) and the defenses against it are present and genetically regulated in CR [6] . Changes in gene expression through regulation of the transcription factors [7, 8] are essential components of the mechanism that determine the cellular response to oxidative damage [9, 10] . Ozone (O 3 )-like molecule is generated in the body during regulation of the immune system [11] . However, by using appropriate dosage and administration route, O 3 can induce a temporary and controlled OS that finally enhances antioxidant defense mechanisms and modulates the immune system [12, 13] . This in turn leads to less [12, 13, 18, 20] and increases oxygen delivery to tissues [21, 22] . From these findings, our objective was to assess whether O 3 treatment could ameliorate CR in LT.
Material and Methods

Design of the Study
This study was approved by the institutional animal care committee and followed the Guide for the Care and Use of Laboratory Animals. A total of 36 Sprague-Dawley male inbred rats (300 to 400 g) were used under optimal conditions and randomly assigned into four groups: (1) the control group (n ¼ 6) underwent left thoracotomy, and samples were taken immediately from the healthy left lung; (2) 
Postoperative Outcome
Tachypnea, stridor, hemoptysis, and abnormal postures were evaluated during the postoperative period, considering the time and possible cause of death.
Histologic Determinations
Euthanasia of sham and animals that received a transplant was performed 3 months after LT. Rat lung isografts were excised for histologic and molecular evaluation. LT specimens were serially sliced into 10-mm-thick sections and stained with hematoxylin and eosin. An expert LT pathologist (T.M.), blinded to the experimental history of the specimens, performed the pathologic studies. Acute rejection (AR) was evaluated according to the international classification [24] . CR was evaluated according to the presence of signs of CR, such as intimal hyperplasia, periarteriolar fibrosis, interstitial fibrosis, peribroncholar fibrosis, and bronchiectasis and was classified as mild, moderate, or severe [6] .
Gene Determinations
Total RNA was isolated by homogenization of frozen tissue using a homogenizer (Polytron PT-2000; Kinematica AG, Luzern, Switzerland) and TriReagent (Sigma, Madrid, Spain), according to the manufacturer's protocol. All samples were treated with RNase-free DNase (Promega, Madison, WI). RNA yields were measured by ultraviolet absorbance, and the quality of total RNA was analyzed with a Bioanalyzer (Model 2100; Agilent Technologies, Palo Alto, CA). The mRNA expression levels of the possible genes involved were measured using quantitative polymerase chain reaction (qPCR) to explore the molecular actions of O 3 treatment (Supplemental Table 1 ). For qPCR, 1 mg of total RNA was treated with RNase-free DNase I (Promega) to remove genomic DNA and was reverse-transcribed using a reverse transcriptase kit (iScript; Bio-Rad Laboratories, Li ege, Belgium). Two microliters of cDNA served as a template in a 20-mL qPCR reaction mix containing the primers and SYBR Green PCR Master Mix (Diagenode, Liege, Belgium). Quantification of gene expression was performed on a sequencedetection system (ABI-PRISM 7000 SD RT-PCR; Applied Biosystems, Foster City, CA) according to the manufacturer's protocol. A dissociation protocol was done to assess the specificity of the primers and the uniformity of the PCR-generated products. The amplified PCR products were subjected to electrophoresis on a 1.5% agarose gel to confirm predicted sizes. Data were extracted, and amplification plots were generated using ABI SDS software. Exon-specific primers were designed by the PRIMER 3 program (Supplemental Table 1 ) [25] . The level of individual mRNA measured by qPCR was normalized to the level of the housekeeping genes cyclophilin and ribosomal 28S by using the Pfaffl method [26] . For graphing purposes, the relative expression levels were scaled such that the expression of the healthy lung control group equaled one.
Statistical Analyses
Statistical evaluation of histologic findings was performed after samples were graded using standardized nomenclature. Comparisons among the categorical variables were assessed with the c 2 test. Differences in gene expression activity by qPCR were tested using the MannWhitney U test. Data management and statistical analyses were performed using SPSS (version 15.0; SPSS Inc, Chicago, IL) statistical software. The value of p less than 0.05 was considered statistically significant.
Results
Postoperative Outcome
All operated animals had a good postoperative outcome, except 2 animals of the LT group that presented with signs of respiratory failure during the first 24 hours. All animals survived the 3-month period up to the sacrifice.
